Evaluated screen

Animal Testing for Medical Products

Identifies companies and other entities that conduct, commission, or control animal testing for the research, development, safety assessment, quality control, or regulatory approval of human pharmaceuticals, biologics, vaccines, or medical devices. The study purpose, species, own or commissioned role, regulatory status, and availability of accepted non-animal methods are evidence attributes. Non-medical testing, distribution without research responsibility, academic non-commercial research, and verified operations using only non-animal methods are excluded.

Type
Evaluated
Version
2026.08.21.2
Published
Aug 21, 2026
Inclusions
6
Exclusions
6
How to read this definition

Inclusion criteria describe evidence that can establish this activity. Exclusion criteria identify circumstances that do not establish it on that basis alone. The evaluation remains connected to its taxonomy version and supporting evidence.

Can establish this activity

Included when supported

Evidence may support involvement when it matches one or more of these inclusion criteria.

6 criteria
  1. 01Criterion

    Include pharmaceutical companies that conduct, commission, fund, or control animal studies for human drug discovery, development, safety, quality, or regulatory purposes.

  2. 02Criterion

    Include biotechnology companies using animal models in the commercial development of human biologics, gene or cell therapies, or other medical products.

  3. 03Criterion

    Include vaccine developers and manufacturers that conduct or commission animal studies for human vaccines.

  4. 04Criterion

    Include medical-device companies that conduct or commission animal studies for biocompatibility, performance, safety, training, or regulatory approval.

  5. 05Criterion

    Include contract research organizations, laboratories, breeders, and testing facilities that commercially perform animal studies for medical-product clients.

  6. 06Criterion

    Include animal studies conducted to satisfy medical-product regulatory requirements; record whether the study was legally required, expected, voluntary, or replaceable by an accepted alternative.

Does not establish this activity on its own

Excluded on this basis alone

These circumstances do not establish this activity unless separate evidence also meets an inclusion criterion.

6 criteria
  1. 01Criterion

    Exclude animal testing for cosmetics, household, industrial, chemical, or other non-medical products.

  2. 02Criterion

    Exclude medical-product developers whose documented current programme uses only accepted non-animal methods and does not conduct, commission, or rely on animal studies.

  3. 03Criterion

    Exclude testing limited to veterinary medicines or animal-health products when the selected client scope covers only human healthcare; record this as a configurable policy choice.

  4. 04Criterion

    Exclude academic, government, charitable, or other non-commercial research institutions unless the taxonomy’s entity scope or client policy expressly includes them.

  5. 05Criterion

    Exclude distributors, pharmacies, hospitals, and service providers without research, development, testing, or commissioning responsibility.

  6. 06Criterion

    Exclude current involvement where reliable evidence establishes complete cessation of animal testing in the relevant medical-development activities; preserve historical involvement and dates.

Evidence and evaluation methodology

How sources, entity pathways, decisions, qualifiers, and review history are handled.

Map screens to a client policy

How to choose provider screens, document coverage, and decide what happens after an outcome.

Other screens under Animal Welfare

Taxonomy version 2026.08.21.2, published Aug 21, 2026. Material changes receive a new immutable release so earlier evaluations remain tied to the definitions and criteria used.

Animal Welfare